Search Legislation

Commission Regulation (EC) No 761/2009Show full title

Commission Regulation (EC) No 761/2009 of 23 July 2009 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Text with EEA relevance)

 Help about what version

What Version

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

This is the original version as it was originally adopted in the EU.
This legislation may since have been updated - see the latest available (revised) version

3.REPORTING

3.1.TEST REPORT

The test report should include the following information:

Test and Control Substances:

  • chemical name(s) such as IUPAC or CAS name and CAS number, if known,

  • purity and composition of the substance (in percentage(s) by weight),

  • physical-chemical properties relevant to the conduct of the study (e.g. physical state, stability and volatility, pH, water solubility if known),

  • treatment of the test/control substances prior to testing, if applicable (e.g. warming, grinding),

  • storage conditions.

Justification of the skin model and protocol used.

Test Conditions:

  • cell system used,

  • calibration information for measuring device, and bandpass used for measuring cell viability (e.g. spectrophotometer),

  • complete supporting information for the specific skin model used including its performance. This should include, but is not limited to:

    (i)

    viability;

    (ii)

    barrier function;

    (iii)

    morphology;

    (iv)

    reproducibility and predictivity;

    (v)

    quality controls (QC) of the model;

  • details of the test procedure used,

  • test doses used, duration of exposure and post treatment incubation period,

  • description of any modifications of the test procedure,

  • reference to historical data of the model. This should include, but is not limited to:

    (i)

    acceptability of the QC data with reference to historical batch data;

    (ii)

    acceptability of the positive and negative control values with reference to positive and negative control means and ranges,

  • description of evaluation criteria used including the justification for the selection of the cut-off point(s) for the prediction model.

Results:

  • tabulation of data from individual test samples,

  • description of other effects observed.

Discussion of the results.

Conclusions.

Back to top

Options/Help

Print Options

You have chosen to open the Whole Regulation

The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources